![Gudrun Bachmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gudrun Bachmann
Technik-/Wissenschafts-/F&E-Leiter bei
OCULIS HOLDING AG
Profil
Gudrun Bachmann currently works at Oculis Holding AG, as Chief Technology Officer from 2024.
Dr. Bachmann also formerly worked at Sandoz AG, as Head-Biopharmaceutical Development from 2012 to 2014, Fresenius Kabi Schweiz AG, as Global Head-CMC leads from 2020 to 2022, and Alvotech hf, as Head-Drug Product Biopharmaceutical Development from 2015 to 2018.
Dr. Bachmann received her graduate degree from the University of Aalborg and doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Aktive Positionen von Gudrun Bachmann
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULIS HOLDING AG | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2024 |
Ehemalige bekannte Positionen von Gudrun Bachmann
| Unternehmen | Position | Ende |
|---|---|---|
Fresenius Kabi Schweiz AG | Corporate Officer/Principal | 01.01.2022 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01.01.2018 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Gudrun Bachmann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
University of Aalborg
 University of Aalborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi Schweiz AG | |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Institute of Cancer Research Royal Marsden Hospital
 Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
